Long-term treatment of hypogonadal men with testosterone produces substantial and sustained weight loss

A randomized, double-blind, placebo-controlled trial of testosterone gel on body composition and health-related quality-of-life in men with hypogonadal to low-normal levels of serum testosterone and symptoms of androgen deficiency over 6 months with 12 months open-label follow-up

(2012) Hermann M. Behre et al.   Aging Male

Effects of long-acting testosterone undecanoate on bone mineral density in middle-aged men with late-onset hypogonadism and metabolic syndrome: results from a 36 months controlled study

(2012) Antonio Aversa et al.   Aging Male

Goodbye Androgen Hypothesis, Hello Saturation Model

(2012) Abraham Morgentaler   EUROPEAN UROLOGY

Serum Testosterone and Dihydrotestosterone and Prostate Cancer Risk in the Placebo Arm of the Reduction by Dutasteride of Prostate Cancer Events Trial

(2012) Roberto L. Muller et al.   EUROPEAN UROLOGY

Effect of Testosterone Supplementation With and Without a Dual 5α-Reductase Inhibitor on Fat-Free Mass in Men With Suppressed Testosterone Production

(2012) Shalender Bhasin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Impact of testosterone on body fat composition

(2012) Chiara De Maddalena et al.   JOURNAL OF CELLULAR PHYSIOLOGY

IPASS: A Study on the Tolerability and Effectiveness of Injectable Testosterone Undecanoate for the Treatment of Male Hypogonadism in a Worldwide Sample of 1,438 Men

(2012) Michael Zitzmann et al.   Journal of Sexual Medicine

Prostate-Cancer Mortality at 11 Years of Follow-up

(2012) Fritz H. Schröder et al.   NEW ENGLAND JOURNAL OF MEDICINE

Low Testosterone Associated With Obesity and the Metabolic Syndrome Contributes to Sexual Dysfunction and Cardiovascular Disease Risk in Men With Type 2 Diabetes

(2011) C. Wang et al.   DIABETES CARE

Metabolic effects of bariatric surgery in type 2 diabetic patients with body mass index < 35 kg/m2

(2011) Q. Li et al.   DIABETES OBESITY & METABOLISM

Reference Ranges for Testosterone in Men Generated Using Liquid Chromatography Tandem Mass Spectrometry in a Community-Based Sample of Healthy Nonobese Young Men in the Framingham Heart Study and Applied to Three Geographically Distinct Cohorts

(2011) Shalender Bhasin et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Body Mass Index Regulates Hypogonadism‐Associated CV Risk: Results from a Cohort of Subjects with Erectile Dysfunction

(2011) Giovanni Corona et al.   Journal of Sexual Medicine

A Two-Year Randomized Trial of Obesity Treatment in Primary Care Practice

(2011) Thomas A. Wadden et al.   NEW ENGLAND JOURNAL OF MEDICINE

Comparative Effectiveness of Weight-Loss Interventions in Clinical Practice

(2011) Lawrence J. Appel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Losing the War Against Obesity: The Need for a Developmental Perspective

(2011) P. D. Gluckman et al.   Science Translational Medicine

Testosterone and cardiovascular disease: An old idea with modern clinical implications

(2010) Abdulmaged M. Traish et al.   ATHEROSCLEROSIS

Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: the double-blinded placebo-controlled Moscow study

(2010) Svetlana Y. Kalinchenko et al.   CLINICAL ENDOCRINOLOGY

Increase in visceral and subcutaneous abdominal fat in men with prostate cancer treated with androgen deprivation therapy

(2010) E. J. Hamilton et al.   CLINICAL ENDOCRINOLOGY

Testosterone Concentrations in Diabetic and Nondiabetic Obese Men

(2010) S. Dhindsa et al.   DIABETES CARE

The therapeutics of lifestyle management on obesity

(2010) P. A. Dyson   DIABETES OBESITY & METABOLISM

Effects of Testosterone on Muscle Strength, Physical Function, Body Composition, and Quality of Life in Intermediate-Frail and Frail Elderly Men: A Randomized, Double-Blind, Placebo-Controlled Study

(2010) Upendram Srinivas-Shankar et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Testosterone Threshold Levels and Lean Tissue Mass Targets Needed to Enhance Skeletal Muscle Strength and Function: The HORMA Trial

(2010) F. Sattler et al.   JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

(2010) W. Philip T. James et al.   NEW ENGLAND JOURNAL OF MEDICINE

Mortality Results from a Randomized Prostate-Cancer Screening Trial

(2009) Gerald L. Andriole et al.   NEW ENGLAND JOURNAL OF MEDICINE

Shifting the Paradigm of Testosterone and Prostate Cancer: The Saturation Model and the Limits of Androgen-Dependent Growth

(2008) Abraham Morgentaler et al.   EUROPEAN UROLOGY

Testosterone treatment in elderly men with subnormal testosterone levels improves body composition and BMD in the hip

(2008) J Svartberg et al.   INTERNATIONAL JOURNAL OF IMPOTENCE RESEARCH

The Dark Side of Testosterone Deficiency: I. Metabolic Syndrome and Erectile Dysfunction

(2008) A. M. Traish et al.   JOURNAL OF ANDROLOGY

Testosterone Therapy Prevents Gain in Visceral Adipose Tissue and Loss of Skeletal Muscle in Nonobese Aging Men

(2007) C. A. Allan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Prevalence of hypogonadism in males aged at least 45 years: the HIM study

(2006) T. MULLIGAN et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE